Category
Pharmaceuticals
-
•
MIWatch.org calls for real disclosure reform
Phyllis Vine at MIWatch.org, a site that follows news about mental illness, asks whether drug company disclosures about payments made…
-
•
Grassley compares ghostwriting, plagiarism
Sen/ Charles Grassley (R-Iowa) continues his investigation of “medical ghostwriting” with a letter to 10 medical schools asking “what they…
-
•
Promoting off-label use is too profitable to ignore
In a special report titled “Big Pharma’s Crime Spree,” David Evans of Bloomberg Markets writes that pharmaceutical companies continue to…
-
They gave us Part D, now protect it from reform
ProPublica’s Olga Pierce reports that at least 25 of the folks who helped push through pharma-friendly Medicare Part D six…
-
•
Feds take Columbia to task over decade-old study
The run of intriguing health journalism from the Huffington Post Investigative Fund continues this week, as Jeanne Lenzer and Shannon…
-
•
Pfizer to pay $75mil for unethical Nigeria drug trial
The Independent‘s Daniel Howden reports that, for about $75 million, Pfizer has settled cases related to a disastrous unlicensed medical…
-
•
Foundation lived by big pharma, now dies by big pharma
Kris Hundley of the St. Petersburg Times reports that the Ischemia Research and Education Foundation, which maintained a massive patient…
-
•
Document shows how Lexapro became blockbuster
The New York Times‘ Gardiner Harris digs into just what a recently released document (89-page pdf) shows us about how…
-
•
FDA drug-monitoring system tricky, promising
Doctors Jerry Avorn and Sebastian Schneeweiss write in the New England Journal of Medicine that the Sentinel Network the FDA…
-
AIDS advocates: Obama needs to use leverage
The Chicago Tribune‘s Tom Hamburger reports that several global health advocacy organizations, including Doctors without Borders and OxFam International, have…